| Phase 3 |
| NCT07225972 |
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and… |
CMV |
Recruiting |
2026-09-11 |
| Phase 2 |
| NCT02675959 |
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With… |
Sickle Cell Disease |
Recruiting |
2026-07-27 |
| NCT07013565 |
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL |
Anaplastic Large Cell Lymphoma, ALK-Positive |
Recruiting |
2026-05-20 |
| NCT05987124 |
Defibrotide Dose-escalation for SOS Post-HSCT |
Sinusoidal Obstruction Syndrome |
Recruiting |
2026-04-15 |
| NCT05564598 |
CMV CTLs in Neonates With CMV Infection |
Congenital Cytomegaloviral (CMV) Disease |
Recruiting |
2026-03-30 |
| NCT02393157 |
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL |
Non-Hodgkin Lymphoma |
Recruiting |
2025-08-08 |
| NCT03266627 |
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection |
Adenovirus |
Recruiting |
2025-08-08 |
| NCT03266640 |
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) |
Cytomegalovirus Infections |
Recruiting |
2025-08-08 |
| NCT03266653 |
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection |
Epstein-Barr Virus Infections |
Recruiting |
2025-08-08 |
| NCT05253495 |
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma |
Non-hodgkin Lymphoma |
Recruiting |
2025-06-13 |
| NCT01461837 |
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease |
Sickle Cell Disease |
Active, Not Recruiting |
2025-08-08 |
| Phase 1/2 |
| NCT04197596 |
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells… |
Viral Infection |
Recruiting |
2026-04-15 |
| NCT04491370 |
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell… |
B-cell Lymphoma |
Recruiting |
2026-04-15 |
| NCT04896606 |
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease |
Covid19 |
Recruiting |
2026-04-13 |
| NCT06617286 |
CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma |
Classical Hodgkin Lymphoma |
Not Yet Recruiting |
2026-04-15 |
| Phase 1 |
| NCT04972942 |
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With… |
T-cell Acute Lymphoblastic Leukemia |
Recruiting |
2026-09-11 |
| NCT04308330 |
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS… |
Ewing Sarcoma |
Recruiting |
2026-04-15 |
| NCT04323748 |
Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura |
Immune Thrombocytopenic Purpura |
Recruiting |
2026-04-15 |
| NCT07575893 |
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma |
Classical Hodgkin Lymphoma |
Not Yet Recruiting |
2026-05-20 |
| Early Phase 1 |
| NCT03719105 |
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma |
NK-Cell Lymphoma |
Recruiting |
2026-08-18 |
| Not applicable |
| NCT07772154 |
Virtual Tai Chi for Chronic Low Back Pain (Spine 2027) |
Low Back Pain |
Not Yet Recruiting |
2026-08-19 |
| NCT07000019 |
Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors |
Stroke |
Not Yet Recruiting |
2025-05-31 |
| Not specified |
| NCT07814079 |
Targeted Ablation to Isolate Scar Channels Causing Ventricular Tachycardia |
Ventricular Tachycardia (VT) |
Recruiting |
2026-09-10 |
| NCT02249923 |
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry |
Pulmonary Vascular Disease |
Recruiting |
2025-03-13 |